Beacon Investment Advisory Services’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,000
Closed -$223K 302
2021
Q4
$223K Hold
5,000
0.01% 289
2021
Q3
$252K Hold
5,000
0.01% 267
2021
Q2
$392K Hold
5,000
0.02% 233
2021
Q1
$286K Hold
5,000
0.01% 257
2020
Q4
$419K Buy
+5,000
New +$419K 0.02% 200